Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study - Illei, G G; Shirota, Y; Yarboro, C H (Arthritis Rheum, 2010)
et al.